Enbrel® (etanercept) is a prescription medicine used to treat five chronic diseases, including moderate to severe rheumatoid arthritis. These highlights do not include all the information needed to use Enbrel safely and effectively. See full prescribing information for Enbrel. Enbrel® (etanercept). What is Enbrel (etanercept) and what is it used for? of Product Characteristics ( SPC) for Enbrel these can be found at the electronic Medicines Compendium.
|Published (Last):||14 December 2018|
|PDF File Size:||8.59 Mb|
|ePub File Size:||8.22 Mb|
|Price:||Free* [*Free Regsitration Required]|
In another open-label single-arm study, 60 patients with extended oligoarthritis 15 patients aged 2 to 4, 23 patients aged 5 to 11 and 22 patients aged 12 to 17 years old38 patients with enthesitis-related arthritis 12 to 17 years oldand 29 patients with psoriatic arthritis 12 to 17 years old were treated with Enbrel at a dose of 0. TNF and lymphotoxin exist predominantly as homotrimers, with their biological activity dependent on cross-linking fnbrel cell surface TNFRs. Enbrel is also indicated in the treatment of severe, active and progressive rheumatoid arthritis in adults not previously treated with methotrexate.
The half-life is long, approximately 70 hours.
Search for a Medicine
These include rare reports of pancytopenia and very rare reports of aplastic anaemia. The mean serum enbtel trough concentrations ranged from 1. Special populations Renal and hepatic impairment No dose adjustment is required. However, it cannot enbreel excluded that the combination of Enbrel with methotrexate could be associated with an increase in the rate of infections. Caution should be exercised when considering TNF-antagonist therapy for patients with a history of malignancy or when considering continuing treatment in patients who develop a malignancy.
Special populations Renal impairment Although there is elimination of radioactivity in urine after administration of radiolabelled etanercept to patients and volunteers, increased etanercept concentrations were not observed in patients with acute renal failure.
No treatment was given for the majority of injection site reactions in the Enrbel treatment groups, and the majority of patients who were given treatment received topical preparations, such as corticosteroids, or oral antihistamines. The proteins were separated by electrophoresis and the gel was stained with 0. Juvenile idiopathic arthritis Treatment of polyarthritis rheumatoid spcc positive or negative and extended oligoarthritis in children and adolescents from the age of 2 years who have had dnbrel inadequate response to, or who have proved intolerant of, methotrexate.
The results of the stability study testing, indicating the period at which the various etanercept DP presentations remain within specification, are summarized in Table 2. In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products. No increase in the incidence of serious infections was observed in trials.
Etanercept (Enbrel®) alternative storage at ambient temperature
Find out more here. Clinical responses among nr-AxSpa patients who received Enbrel were apparent at the time of the first visit 2 weeks and were maintained through 2 years of therapy. Patient-reported outcomes in a randomized trial comparing four different treatment strategies in recent-onset rheumatoid arthritis.
Adult patients with rheumatoid arthritis The efficacy of Enbrel was assessed in a randomised, double-blind, placebo-controlled study. In plaque psoriasis, infiltration by inflammatory cells, including T-cells, leads to increased TNF levels in psoriatic lesions compared with levels in uninvolved skin.
Any unused product or waste material should be disposed of in accordance with local requirements. Pregnancy Developmental toxicity studies performed in rats and rabbits have revealed no evidence of harm to the foetus or neonatal rat due to etanercept. Rheumatoid arthritis Enbrel in combination with methotrexate is indicated for the treatment of moderate to severe active rheumatoid arthritis in adults when the response to disease-modifying antirheumatic drugs, including methotrexate unless contraindicatedhas been inadequate.
What did the researchers do and find? Etanercept is slowly absorbed from the site of subcutaneous injection, reaching maximum concentration approximately 48 hours after a single dose.
In an open-label, safety extension study, 58 paediatric patients from the above study from the age of 4 years at time of enrollment continued to receive Enbrel for up to 10 years. Interactions between etanercept and other drugs have not been evaluated in formal studies.
Enbrel 25 mg powder and solvent for solution for injection
Analysis Statistical analysis was performed on the following quantitative stability-indicating parameters: In ennbrel clinical trials of etanercept across all indications, the frequency incidence proportion of interstitial lung disease in patients receiving etanercept without concomitant methotrexate was 0. Additionally, the pharmacokinetics of Enbrel in rheumatoid arthritis patients, ankylosing spondylitis and plaque psoriasis patients are similar.
Neurological disorders There have been rare reports of CNS demyelinating disorders in patients treated with Enbrel see section 4.
Results from an inception cohort with 24 years follow-up. No studies on the effects on the ability to drive and use machines have been performed. Patients with complete ankylosis of the spine were not included in the study. In the controlled clinical trials that allowed concomitant treatment with etanercept and methotrexate, the frequency incidence proportion of autoimmune hepatitis was 0. The other cases represented a variety of different malignancies and included rare malignancies typically associated with immunosuppression.
Patients can enroll by visiting EnbrelSupport. Long-term studies to assess the safety of the combination are ongoing.